Year Established :
1987
Total Assets(USD) :
35,000,000 To 39,999,999
Total Number of Staff :
450 to 499
Main Competitive Advantages :
Brandname,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production capacity,Large Product Line,Buyers Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages :
professional & efficient sales team
Strong technical support and applications guidance
Patents and Copyrights :
having own patents
Business Type :
Manufacturer
R&D Capacity :
Own brand
Annual Turnover(USD) :
35,000,000 To 39,999,999
Main Sales Markets :
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Main Product Categorise :
Active Pharmaceutical Ingredients,Excipients,Finished Dosage
Product Range :
Povidone (PVP K series including PVP K12, PVP K15, PVP K17, PVP K25, PVP K30, PVP K60, PVP K90, PVP K120)
Copovidone (PVP VA64 powder)
Crospovidone (Type A, Type B)
Povidone Iodine (PVP-Iodine complex)
PVM/MA Copolymers series
Gamma Butyrolactone(GBL), 2-Pyrrolidone, N-vinyl pyrrolidone(NVP)
Vinyl ethers (Methy Vinyl Ether, Ethyl Vinyl Ether, N-Butyl Vinyl Ether, Tert-Butyl Viny Ether, etc.)